Baseline Clinical and Blood Biomarker in Patients With Preataxic and Early-Stage Disease Spinocerebellar Ataxia 1 and 3.
Sophie Tezenas Du MontcelEmilien PetitTitilayo OlubajoJennifer FaberPauline Lallemant-DudekKhalaf BusharaSusan PerlmanSub H SubramonyDavid MorganBrianna JackmanHenry Lauris PaulsonGülin ÖzThomas KlockgetherAlexandra DürrTetsuo Ashizawanull nullPublished in: Neurology (2023)
READISCA showed the feasibility of harmonized data acquisition in a multi-national network. NfL alterations, early sensory ataxia and corticospinal signs were quantifiable between preataxic participants and controls. Patients with ataxia differed in many parameters from controls and mutation carriers without ataxia, with a graded increase of abnormal measures from control to preataxic to ataxic cohorts.